Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in large- and medium-sized arteries and is morphologically characterized by asymmetric focal thickenings of the innermost layer of the artery, the intima. This process is the basis of cardiovascular diseases (CVDs)...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/11/4/1206 |
| _version_ | 1797606272443351040 |
|---|---|
| author | Carles Vilaplana-Carnerero Maria Giner-Soriano Àngela Dominguez Rosa Morros Carles Pericas Dolores Álamo-Junquera Diana Toledo Carmen Gallego Ana Redondo María Grau |
| author_facet | Carles Vilaplana-Carnerero Maria Giner-Soriano Àngela Dominguez Rosa Morros Carles Pericas Dolores Álamo-Junquera Diana Toledo Carmen Gallego Ana Redondo María Grau |
| author_sort | Carles Vilaplana-Carnerero |
| collection | DOAJ |
| description | Atherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in large- and medium-sized arteries and is morphologically characterized by asymmetric focal thickenings of the innermost layer of the artery, the intima. This process is the basis of cardiovascular diseases (CVDs), the most common cause of death worldwide. Some studies suggest a bidirectional link between atherosclerosis and the consequent CVD with COVID-19. The aims of this narrative review are (1) to provide an overview of the most recent studies that point out a bidirectional relation between COVID-19 and atherosclerosis and (2) to summarize the impact of cardiovascular drugs on COVID-19 outcomes. A growing body of evidence shows that COVID-19 prognosis in individuals with CVD is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with CVD after COVID-19. The most common treatments for CVD may influence COVID-19 outcomes. Thus, their implication in the infection process is briefly discussed in this review. A better understanding of the link among atherosclerosis, CVD, and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients. |
| first_indexed | 2024-03-11T05:12:52Z |
| format | Article |
| id | doaj.art-3cd8d320a07e4295a433c3fe33f5989c |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-11T05:12:52Z |
| publishDate | 2023-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-3cd8d320a07e4295a433c3fe33f5989c2023-11-17T18:28:00ZengMDPI AGBiomedicines2227-90592023-04-01114120610.3390/biomedicines11041206Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative ReviewCarles Vilaplana-Carnerero0Maria Giner-Soriano1Àngela Dominguez2Rosa Morros3Carles Pericas4Dolores Álamo-Junquera5Diana Toledo6Carmen Gallego7Ana Redondo8María Grau9Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, SpainFundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, SpainDepartment of Medicine, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, SpainFundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, SpainDepartment of Medicine, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, SpainDepartment of Medicine, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, SpainDepartment of Medicine, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, SpainDepartment of Medicine, School of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, SpainHospital Universitario Bellvitge, Catalan Institute of Health (ICS), 08907 Barcelona, SpainBiomedical Research Consortium in Epidemiology and Public Health (CIBERESP), 28029 Madrid, SpainAtherosclerosis is a chronic inflammatory and degenerative process that mainly occurs in large- and medium-sized arteries and is morphologically characterized by asymmetric focal thickenings of the innermost layer of the artery, the intima. This process is the basis of cardiovascular diseases (CVDs), the most common cause of death worldwide. Some studies suggest a bidirectional link between atherosclerosis and the consequent CVD with COVID-19. The aims of this narrative review are (1) to provide an overview of the most recent studies that point out a bidirectional relation between COVID-19 and atherosclerosis and (2) to summarize the impact of cardiovascular drugs on COVID-19 outcomes. A growing body of evidence shows that COVID-19 prognosis in individuals with CVD is worse compared with those without. Moreover, various studies have reported the emergence of newly diagnosed patients with CVD after COVID-19. The most common treatments for CVD may influence COVID-19 outcomes. Thus, their implication in the infection process is briefly discussed in this review. A better understanding of the link among atherosclerosis, CVD, and COVID-19 could proactively identify risk factors and, as a result, develop strategies to improve the prognosis for these patients.https://www.mdpi.com/2227-9059/11/4/1206COVID-19atherosclerosiscardiovascular diseaselong COVIDbidirectional linkcardiovascular disease treatments |
| spellingShingle | Carles Vilaplana-Carnerero Maria Giner-Soriano Àngela Dominguez Rosa Morros Carles Pericas Dolores Álamo-Junquera Diana Toledo Carmen Gallego Ana Redondo María Grau Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review Biomedicines COVID-19 atherosclerosis cardiovascular disease long COVID bidirectional link cardiovascular disease treatments |
| title | Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review |
| title_full | Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review |
| title_fullStr | Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review |
| title_full_unstemmed | Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review |
| title_short | Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review |
| title_sort | atherosclerosis cardiovascular disease and covid 19 a narrative review |
| topic | COVID-19 atherosclerosis cardiovascular disease long COVID bidirectional link cardiovascular disease treatments |
| url | https://www.mdpi.com/2227-9059/11/4/1206 |
| work_keys_str_mv | AT carlesvilaplanacarnerero atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT mariaginersoriano atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT angeladominguez atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT rosamorros atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT carlespericas atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT doloresalamojunquera atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT dianatoledo atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT carmengallego atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT anaredondo atherosclerosiscardiovasculardiseaseandcovid19anarrativereview AT mariagrau atherosclerosiscardiovasculardiseaseandcovid19anarrativereview |